23andMe Founder's $305M Bid Buys Back Co. In Ch. 11 Sale
By Bonnie Eslinger · June 13, 2025, 8:54 PM EDT
With a winning bid of $305 million, a nonprofit controlled by 23andMe founder Anne Wojcicki beat out Regeneron Pharmaceuticals to purchase the bankrupt company's assets, 23andMe announced Friday....
To view the full article, register now.